Neurocrine Biosciences
NBIX
$134.19
Share price
0.36%
Change (1 day)
-7.61%
Change (1 year)
Categories
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.
Operating Margin for Neurocrine Biosciences (NBIX)
Operating Margin as of July 2025 (TTM): 20.63%
According to Neurocrine Biosciences 's latest financial reports and stock price the company's current Operating Margin is 20.63%. At the end of 2024 the company had an Operating Margin of 20.63%.
Operating Margin history for Neurocrine Biosciences from 2001 to 2025
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2024 | 20.63% | 17.25% |
| 2023 | 17.60% | 22.48% |
| 2022 | 14.37% | 60.62% |
| 2021 | 8.95% | -12.31% |
| 2020 | 10.20% | 72.9% |
| 2019 | 5.90% | 22.12% |
| 2018 | 4.83% | -105.48% |
| 2017 | -88.19% | -90.62% |
| 2016 | -940.60% | 109.1% |
| 2015 | -449.84% | |
| 2013 | -1,578.97% | -16797.76% |
| 2012 | 9.46% | -80.52% |
| 2011 | 48.53% | -304.06% |
| 2010 | -23.78% | -98.62% |
| 2009 | -1,728.34% | -22.47% |
| 2008 | -2,229.26% | -86.84% |
| 2007 | -16,936.19% | 6098.17% |
| 2006 | -273.25% | 1425.49% |
| 2005 | -17.91% | -66.61% |
| 2004 | -53.65% | 147.89% |
| 2003 | -21.64% | -95.87% |
| 2002 | -523.89% | 487.29% |
| 2001 | -89.21% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Repligen
RGEN | -4.26% | -120.65% | 🇺🇸 USA |
 Royalty Pharma RPRX | 89.01% | 331.46% | 🇬🇧 UK |
 Palatin Technologies PTN | -662.26% | -3,310.18% | 🇺🇸 USA |
 Eli Lilly LLY | 27.75% | 34.51% | 🇺🇸 USA |
 AbbVie ABBV | 6.31% | -69.41% | 🇺🇸 USA |
 Pfizer PFE | 12.60% | -38.92% | 🇺🇸 USA |
 ANI Pharmaceuticals ANIP | -4.08% | -119.78% | 🇺🇸 USA |
 Athersys ATHX | -1,576.98% | -7,744.11% | 🇺🇸 USA |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.